Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
Journal of the American Heart Association 2018 04 137(8) pii 10.1161/JAHA.118.008643 Abstract BACKGROUND Frailty predicts poorer outcomes and decreased anticoagulation use in patients with nonvalvular atrial fibrillation. We...
Read More